Belgicko - francúzština - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

pfizer sa-nv - chlorhydrate d'epirubicine 200 mg - solution intravésicale/injectable - chlorhydrate d'epirubicine 200 mg - epirubicin

Belgicko - francúzština - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

pfizer sa-nv - chlorhydrate d'epirubicine 50 mg - solution intravésicale/injectable - chlorhydrate d'epirubicine 50 mg - epirubicin

Belgicko - francúzština - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

pfizer sa-nv - chlorhydrate d'epirubicine 2 mg/ml - solution injectable - chlorhydrate d'epirubicine 50 mg - epirubicin

Tunisko - francúzština - Ministère de la Santé, Direction de l'inspection Pharmaceutique

pfizer holding france - epirubicine - solution injectable pour perfusion - 50 mg/25 ml - antineoplasiques et immunomodulateurs - antineoplasiques - - carcinomes mammaires; - cancers de l'ovaire; - lymphomes malins non hodgkiniens, maladie de hodgkin; - cancers microcellulaires du poumon; - sarcomes des parties molles; - cancers de l'oesophage, de l'estomac, du pancréas hépatocellulaires; - cancers épidermoïdes de la sphère orl.

Tunisko - francúzština - Ministère de la Santé, Direction de l'inspection Pharmaceutique

pfizer holding france - epirubicine - solution injectable pour perfusion - 10 mg/5 ml - antineoplasiques et immunomodulateurs - antineoplasiques - - carcinomes mammaires; - cancers de l'ovaire; - lymphomes malins non hodgkiniens, maladie de hodgkin; - cancers microcellulaires du poumon; - sarcomes des parties molles; - cancers de l'oesophage, de l'estomac, du pancréas hépatocellulaires; - cancers épidermoïdes de la sphère orl.

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

pfizer (perth) pty ltd - epirubicin hydrochloride, quantity: 2 mg/ml - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; water for injections - farmorubicina has shown to be effective in a wide range of neoplastic diseases such as: - breast carcinoma. - soft tissue sarcoma - gastric carcinoma. - small cell lung carcinoma. - advanced ovarian carcinoma. farmorubicina may also be used in the treatment of transitional cell bladder carcinoma (ta/t1 and carcinoma in situ) and in the prophylaxis of the rebound of transitional cell bladder tumours with complete transurethral resection. farmorubicina may also be used alone as a single agent or as part of different kinds of polichemotherapy treatments.

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

pfizer (perth) pty ltd - epirubicin hydrochloride, quantity: 2 mg/ml - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; water for injections - farmorubicina tm cs (epirubicin hydrochloride) has a significant therapeutic response in several neoplasms such as: breast carcinoma, malignant lymphomas, soft tissue sarcomas, gastric carcinoma, liver carcinoma, pancreatic cancer, rectum-sigmoid carcinoma, cervical-facial carcinoma, pulmonary carcinoma, ovarian carcinoma and leukemias. farmorubicina tm cs by intravesical instillation is indicated to treat superficial bladder carcinoma (of transitional cells, carcinoma in situ) and for prophylaxis of recurrences after trans-urethral resection.

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

pfizer (perth) pty ltd - epirubicin hydrochloride, quantity: 2 mg/ml - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; water for injections - farmorubicina is used in adults to treat different types of tumour: ? breast cancer; ? malignant lymph node tumours (lymphoma); ? soft tissue tumours (sarcomas); - cancer of the stomach and intestine (sigmoid rectal cancer) ? liver cancer; ? pancreatic cancer; ? cancer of the head or neck (cervical and facial segment) ? lung cancer; ? ovarian cancer; farmorubicina 10 mg/5 ml e 50 mg/25 ml is also administered directly into the bladder (intravesical route), in the treatment of early (superficial) bladder cancer and to prevent bladder cancer relapse after surgery (transurethral resection). blood cancer (leukaemia).

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

pfizer (perth) pty ltd - epirubicin hydrochloride, quantity: 2 mg/ml - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; water for injections - .farmorubicina is used in adults to treat different types of tumour: ? breast cancer; ? malignant lymph node tumours (lymphoma); ? soft tissue tumours (sarcomas); - cancer of the stomach and intestine (sigmoid rectal cancer) ? liver cancer; ? pancreatic cancer; ? cancer of the head or neck (cervical and facial segment) ? lung cancer; ? ovarian cancer; ? blood cancer (leukaemia).

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

pfizer (perth) pty ltd - epirubicin hydrochloride, quantity: 2 mg/ml - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; water for injections - farmorubicin has been shown to be particularly effective in the treatment of breast, ovarian, stomach, colon and lung cancers. furthermore, farmorubicin may be used in the treatment of cancer of the blood-forming organs such as malignant lymphomas, leukaemia and multiple myeloma. farmorubicin may also be injected directly through a tube into the urinary bladder. this method is sometimes used in the treatment of cell abnormalities or bladder wall cancer. it can also be used after other forms of treatment as an attempt to prevent the re-growth of such cells.